BET inhibitors suppress PD-L1 expression in pancreatic stellate cells

被引：0
|
作者：
Ebine, Kazumi
DeCant, Brian T.
Collier, Katharine A.
Pham, Thao N.
Kumar, Krishan
Munshi, Hidayatullah G.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1679
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1679
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PD-L1 Expression on Cell Block Preparations of Pancreatic Adenocarcinoma
    Costa, Victoria
    Kim, David
    Johncilla, Melanie
    Goyal, Abha
    Rao, Rema
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 : S94 - S95
  • [22] BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
    Hogg, Simon J.
    Vervoort, Stephin J.
    Deswal, Sumit
    Ott, Christopher J.
    Li, Jason
    Cluse, Leonie A.
    Beavis, Paul A.
    Darcy, Phillip K.
    Martin, Benjamin P.
    Spencer, Andrew
    Traunbauer, Anna K.
    Sadovnik, Irina
    Bauer, Karin
    Valent, Peter
    Bradner, James E.
    Zuber, Johannes
    Shortt, Jake
    Johnstone, Ricky W.
    CELL REPORTS, 2017, 18 (09): : 2162 - 2174
  • [23] YBX1 is a tuner to suppress PD-L1 expression in some lung cancer
    Mizutani, Yasuyoshi
    Takeuchi, Toshiyuki
    Niimi, Atsuko
    Limsirichaikul, Siripan
    Sawangsri, Patinya
    Tran, Dat Q.
    Inada, Kenichi
    Tsukamoto, Tetsuya
    Kondo, Masashi
    Suzuki, Motoshi
    CANCER SCIENCE, 2023, 114 : 276 - 276
  • [24] Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors
    Salvia, Roser
    Rico, Laura G.
    Moran, Teresa
    Bradford, Jolene A.
    Ward, Michael D.
    Drozdowskyj, Ana
    Climent-Marti, Joan
    Martinez-Caceres, Eva M.
    Rosell, Rafael
    Petriz, Jordi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [25] Regulatory mechanisms of PD-L1 expression in cancer cells
    Shi, Yongyu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (10) : 1481 - 1489
  • [26] PD-L1 expression by circulating breast cancer cells
    David, Rachel
    LANCET ONCOLOGY, 2015, 16 (07): : E321 - E321
  • [27] Beyond inhibition against the PD-1/PD-L1 pathway: development of PD-L1 inhibitors targeting internalization and degradation of PD-L1
    Guo, Jiazheng
    Yu, Fengyi
    Zhang, Kuojun
    Jiang, Sheng
    Zhang, Xiangyu
    Wang, Tianyu
    RSC MEDICINAL CHEMISTRY, 2024, 15 (04): : 1096 - 1108
  • [28] Salmonella induces PD-L1 expression in B cells
    Lopez-Medina, Marcela
    Perez-Lopez, Araceli
    Alpuche-Aranda, Celia
    Ortiz-Navarrete, Vianney
    IMMUNOLOGY LETTERS, 2015, 167 (02) : 131 - 140
  • [29] Regulatory mechanisms of PD-L1 expression in cancer cells
    Yongyu Shi
    Cancer Immunology, Immunotherapy, 2018, 67 : 1481 - 1489
  • [30] Efficacy of PD-1/PD-L1 Immune Checkpoint Inhibitors for Advanced NSCLC According to PD-L1 Expression: A Meta-Analysis
    Ma, K.
    Guo, Y.
    Wang, Y.
    Wang, X.
    Xu, Y.
    Sun, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S584 - S584
12345